Contact with venomous snakes and lizards

VWXY20_CONTACT_W_VENOMO_SNAKES_LIZAR

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — X20 Cause of death: ICD-10 — X20 2 out of 7 registries used, show all original rules.	443
4. Check minimum number of events None	443
5. Include endpoints None	443
6. Filter based on genotype QC (FinnGen only)	400

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: X20-X29

NAME	VWXY20_CONTACT_W_VENOMO_SNAKES_LIZAR
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	X20
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	X20
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Contact with venomous snakes and lizards based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	400	225	175
Unadjusted period prevalence (%)	0.08	0.08	0.08
Median age at first event (years)	52.90	50.17	56.41

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
410: Matched controls
4100

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

X20

ICD-10 Finland

Contact with venomous snakes and lizards

+∞

307.7

405

T63.0

ICD-10 Finland

Toxic effect: Snake venom

4684.1

307.7

345

S13

ICPC

Animal/human bite

5.9

18.2

C01CA24

ATC

epinephrine; parenteral

3.2

10.7

158

T63.9

ICD-10 Finland

Toxic effect: Toxic effect of contact with unspecified venomous animal

+∞

7.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

173

1057

2.10

11.77

2.3

143.65

278.62

u/l

1.34

166

1007

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

181

1348

1.61

5.25

3.9

3.7

18.14

75.76

ng/l

0.76

126

954

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

412

1.87

5.07

4.7

4.8

34.74

31.67

1.53

270

(3019225) pH of Specimen

311

1.97

4.89

2.6

4.2

7.35

0.00

218

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

396

3705

3.02

4.37

11.6

11.8

25.58

26.26

u/l

0.26

385

3609

(3032080) INR in Blood by Coagulation assay

201

1599

1.50

4.02

12.7

12.8

1.22

inr

0.02

170

1327

(3019550) Sodium [Moles/volume] in Serum or Plasma

383

3548

2.21

4.00

16.4

17.9

139.90

139.66

mmol/l

1.32

377

3483

(3002032) Base excess in Venous blood by calculation

348

1.78

3.71

2.4

4.3

1.21

1.81

mmol/l

0.64

294

(3020564) Creatinine [Moles/volume] in Serum or Plasma

395

3724

2.66

3.65

18.7

19.4

73.19

76.19

umol/l

2.45

387

3683

(3021447) Carbon dioxide [Partial pressure] in Venous blood

367

1.74

3.60

2.3

4.2

5.79

5.69

kpa

0.41

356

(3012544) pH of Venous blood

367

1.74

3.60

2.4

4.2

7.37

7.39

0.83

218

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

379

3523

2.00

3.51

14.6

15.3

16.68

23.28

mg/l

6.16

313

2847

(3023103) Potassium [Moles/volume] in Serum or Plasma

381

3550

2.04

3.47

16.7

18.0

3.97

3.96

mmol/l

0.23

375

3475

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

196

1589

1.45

3.36

5.5

7.2

1.21

mmol/l

0.01

181

1469

(3006462) Nitrate [Presence] in Urine

5.91

3.03

1.4

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

247

2131

1.40

2.78

4.5

5.4

6.30

6.60

mmol/l

1.89

234

2006

(4211845) Urine protein measurement

4.73

2.60

1.4

1.5

—

(3022621) pH of Urine by Test strip

295

1.67

2.59

1.6

2.3

6.02

6.13

0.32

195

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

353

3271

1.57

2.57

5.7

5.2

1.96

1.88

mu/l

0.71

328

3028

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

2.78

2.57

2.8

3.1

47.33

17.24

mg/l

—

(3010813) Leukocytes [#/volume] in Blood

401

3878

2.55

2.51

22.9

23.1

6.57

6.69

e9/l

0.62

392

3792

(3026361) Erythrocytes [#/volume] in Blood

401

3876

2.57

2.50

22.8

23.1

4.53

4.52

e12/l

0.07

393

3790

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

210

1785

1.36

2.48

6.0

7.8

1.22

1.21

mmol/l

0.65

183

1547

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

276

2451

1.39

2.46

3.5

3.4

41.52

45.40

u/l

0.53

265

2316

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

350

3248

1.53

2.41

5.9

6.2

38.47

38.89

mmol/mol

0.47

323

3062

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

360

3364

1.58

2.37

13.0

14.6

86.19

84.31

ml/min/173m2

0.99

331

3088

(3024354) Oxygen [Partial pressure] in Venous blood

319

1.61

2.35

2.5

3.7

4.33

4.46

kpa

0.21

309

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

298

2707

1.37

2.12

7.9

8.2

72.47

79.56

u/l

2.96

288

2567

(3007461) Platelets [#/volume] in Blood

400

3872

2.36

2.01

23.0

23.1

245.24

250.98

e9/l

1.22

392

3801

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

1.86

0.0

2.4

—

29.33

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

301

2766

1.33

1.79

4.8

4.2

14.59

14.77

pmol/l

0.68

282

2516

(36660697) Celiac disease serology panel - Serum

333

1.50

1.78

1.3

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

216

0.45

1.77

1.2

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

1.69

0.0

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

2.41

1.63

1.1

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

2.36

1.60

1.1

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

2.36

1.60

1.1

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

2.36

1.60

1.1

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

2.30

1.56

1.1

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

2.30

1.56

1.1

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

545

1.37

1.54

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

176

1530

1.26

1.53

2.0

2.1

95.80

96.71

pmol/l

0.08

805

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

108

1.80

1.53

1.7

1.5

—

(3015736) pH of Urine

181

1579

1.26

1.53

3.4

6.33

6.24

0.53

104

897

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

2.62

1.52

1.1

1.2

2.01

1.85

mmol/l

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

1.50

0.0

1.4

—

87.60

—

(3023520) Reticulocytes [#/volume] in Blood

313

1.45

1.47

1.8

3.0

64.09

70.37

e9/l

0.83

223

(3013115) Eosinophils [#/volume] in Blood

218

1958

1.24

1.38

6.1

6.8

0.16

0.18

e9/l

1.52

199

1725

(4062490) Immunoglobulin typing, IgG

2.22

1.37

1.6

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

104

858

1.28

1.37

3.8

3.7

—

0.30

—

(3028707) Methadone [Presence] in Urine by Screen method

1.79

1.37

1.3

1.8

—

(3009261) Glucose [Presence] in Urine by Test strip

222

2001

1.24

1.35

3.5

3.8

0.00

0.74

estimate

0.50

408

(4034850) Laboratory test

105

1.75

1.35

6.2

10.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

371

1.40

1.34

4.5

6.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

350

3331

1.35

1.33

5.2

4.9

5.82

5.90

mmol/l

0.62

327

3065

(3018010) Neutrophils/Leukocytes in Blood

198

1766

1.23

1.32

5.3

6.5

56.71

57.31

0.31

184

1698

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

286

2656

1.25

1.30

4.3

10.90

11.15

mm/h

0.12

270

2475

(3009343) pH of Capillary blood

253

1.46

1.29

2.4

5.0

7.42

0.00

209

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

195

1.52

1.28

2.2

2.9

0.63

0.62

0.04

195

(3000570) Elastase.pancreatic [Mass/mass] in Stool

115

1.68

1.27

1.4

1.3

243.59

307.76

ug/g

0.56

(3019198) Lymphocytes [#/volume] in Blood

215

1941

1.23

1.26

5.9

6.5

1.81

1.96

e9/l

1.23

197

1727

(3013650) Neutrophils [#/volume] in Blood by Automated count

231

2103

1.23

1.24

8.9

10.0

3.88

4.07

e9/l

0.58

208

1832

(3004616) Nuclear Ab [Presence] in Serum

2.02

1.24

1.6

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

2.02

1.24

1.9

1.4

25.24

30.85

ng/l

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

198

1.50

1.20

4.6

8.9

24.43

24.62

mmol/l

0.13

188

(3022145) Colonoscopy Study observation

405

1.35

1.20

1.2

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

2.13

1.19

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

359

3442

1.35

1.19

5.0

4.57

4.61

mmol/l

0.32

330

3228

(3006315) Basophils [#/volume] in Blood

210

1901

1.21

1.17

5.9

6.5

0.04

e9/l

1.00

184

1645

(42870588) Differential panel, method unspecified - Blood

140

1218

1.23

1.15

4.9

6.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

682

1.27

1.13

1.2

1.3

14.45

32.19

iu/ml

3.23

214

(3001604) Monocytes [#/volume] in Blood

209

1896

1.21

1.12

5.9

6.5

0.56

0.57

e9/l

0.32

184

1641

(3019069) Monocytes/Leukocytes in Blood

194

1748

1.21

1.12

5.4

6.7

9.05

8.75

0.72

178

1660

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

491

1.31

1.12

2.0

1.7

1.51

1.49

0.09

437

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

245

1.42

1.10

1.2

105.03

114.94

u/ml

0.10

104

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.40

1.09

1.0

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.40

1.09

1.0

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

630

1.27

1.09

1.2

1.3

17.51

13.25

u/ml

0.14

258

(3006504) Eosinophils/Leukocytes in Blood

193

1743

1.20

1.07

5.3

6.6

2.68

2.78

0.24

177

1651

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

129

1.58

1.07

1.5

1.9

—

(3027945) Reticulocytes/Erythrocytes in Blood

413

1.33

1.07

1.9

3.0

1.50

1.83

3.16

380

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1.95

1.07

1.1

1.5

0.40

0.53

nmol/l

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

357

3431

1.31

1.06

4.9

1.48

1.46

mmol/l

0.36

327

3197

(3047181) Lactate [Moles/volume] in Blood

1.71

1.02

3.9

11.8

1.39

1.17

mmol/l

0.42

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

107

0.46

1.02

12.8

2.1

0.00

g/l

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

109

0.45

1.02

12.8

2.1

0.00

0.05

g/l

—

102

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

206

1.44

1.02

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.19

0.98

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.19

0.98

1.0

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

2.19

0.98

13.0

12.0

0.58

0.64

mmol/l

—

(3000034) Microalbumin [Mass/volume] in Urine

0.00

0.98

0.0

3.2

—

18.64

—

(3019150) Specific gravity of Urine by Refractometry

101

864

1.22

0.97

3.7

3.8

1.02

kg/l

0.03

575

(3029937) Albumin [Presence] in Urine by Test strip

125

1093

1.21

0.97

3.8

3.9

0.00

0.01

estimate

0.74

401

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

117

1.56

0.95

1.4

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

144

0.55

0.95

9.5

3.2

16.88

1724.90

u/ml

—

122

(3021601) Nitrite [Presence] in Urine by Test strip

214

1967

1.18

0.94

3.5

3.8

0.00

estimate

-0.00

428

(3035350) Ketones [Presence] in Urine by Test strip

216

1987

1.18

0.94

3.6

3.8

0.00

3.76

estimate

0.50

432

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

361

3486

1.30

0.94

5.7

5.6

2.63

2.71

mmol/l

0.99

333

3254

(3002030) Lymphocytes/Leukocytes in Blood

196

1789

1.18

0.93

5.3

6.6

27.91

27.90

0.00

184

1710

(3022096) Basophils/Leukocytes in Blood

191

1740

1.18

0.93

5.4

6.7

0.64

0.68

0.56

175

1644

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

821

1.22

0.93

1.7

2.1

1.25

1.31

mg/l

0.08

644

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

104

0.47

0.90

1.2

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

257

2405

1.18

0.90

3.1

3.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

264

1.36

0.89

2.6

2.5

32.07

16.92

au/ml

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.92

0.89

1.0

1.4

—

nmol/l

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

136

1.49

0.88

1.5

2.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

854

1.21

0.88

1.6

1.4

2.33

2.37

g/l

0.08

525

(3000991) Gas panel - Venous blood

318

1.32

0.88

4.6

11.0

—

(3002582) Erythrocytes [#/volume] in Urine

134

1189

1.19

0.88

3.3

3.2

99.26

100.28

e6/l

0.00

108

902

(3019309) Folate [Moles/volume] in Red Blood Cells

555

1.25

0.87

1.9

1.7

1207.94

1122.05

nmol/l

0.33

416

(3044889) 12 lead EKG panel

230

2461

0.85

0.87

4.2

3.9

—

20203.40

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

112

1.54

0.86

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

330

1.30

0.83

2.7

2.4

10.83

10.33

g/l

0.30

304

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

633

1.23

0.83

2.4

2.9

0.87

0.98

e6/l

0.20

326

(21494815) CD4 cells/Lymphocytes in Specimen

1.89

0.82

1.3

2.1

37.90

36.40

—

(1761868) Lipid panel - Serum or Plasma

129

1438

0.85

0.80

3.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

135

1208

1.18

0.80

3.6

3.3

2.37

2.35

mmol/l

1.30

121

1103

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

405

1.27

0.79

4.1

5.1

226.20

247.60

u/l

1.03

388

(42529406) Shigella sp [Presence] in Stool by Culture

121

0.57

0.79

1.3

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1.68

0.79

1.4

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1.68

0.79

1.4

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.76

0.0

3.9

—

8.34

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

185

1704

1.16

0.74

2.5

2.8

—

estimate

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

159

1.41

0.74

2.0

2.4

4527.81

7270.56

u/l

—

(3025130) Human papilloma virus identified in Specimen

1.65

0.74

1.9

—

(3016018) Differential panel - Cerebral spinal fluid

1.86

0.74

1.1

1.7

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

2.01

0.73

1.0

4.2

74.40

129.76

nmol/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

814

1.18

0.71

1.9

1.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

338

3264

1.20

0.71

4.4

4.2

1.26

1.25

mmol/l

0.00

307

3029

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.72

0.70

1.4

1.0

—

(3044640) Blood type and Crossmatch panel - Blood

132

1191

1.16

0.70

2.2

2.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

109

969

1.17

0.69

1.5

1.3

3.71

1.31

u/ml

0.40

255

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

176

1622

1.15

0.69

2.5

76.40

76.17

nmol/l

0.04

160

1463

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

117

0.59

0.69

1.0

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

226

0.70

0.69

6.1

2.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.86

0.68

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

189

1.34

0.66

1.5

1.6

0.32

0.35

mg/l

0.09

(3023511) Choriogonadotropin [Units/volume] in Urine

1.49

0.65

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.73

0.64

1.0

1.2

133.20

107.86

pmol/l

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

558

1.20

0.62

1.9

2.4

2.38

2.31

g/l

0.40

520

(3000494) Fungus identified in Specimen by Culture

453

0.80

0.62

1.3

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

218

1.31

0.62

2.3

5.3

1.35

1.62

mmol/l

0.23

167

(3020491) Glucose [Moles/volume] in Blood

1.67

0.61

1.2

2.0

7.68

6.26

mmol/l

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

201

1881

1.13

0.61

6.5

6.8

11.16

11.58

umol/l

0.13

196

1803

(3022313) Gas panel - Capillary blood

192

1.32

0.61

2.4

5.4

—

(3023419) Bacteria identified in Sputum by Culture

1.58

0.60

1.6

2.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.60

0.0

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

0.60

0.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

346

1.24

0.60

2.1

2.3

12.75

13.49

nmol/l

0.27

321

(3044290) Cell count panel - Cerebral spinal fluid

1.52

0.60

1.3

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

0.00

0.60

0.0

29.4

—

6.23

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.60

0.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.58

0.0

3.9

—

0.87

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

330

1.24

0.57

3.9

9.6

1.30

1.27

mmol/l

0.08

325

(3011412) CD3 cells [#/volume] in Blood

1.68

0.57

1.5

1.9

1462.50

1023.45

e6/l

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

1.68

0.57

1.0

—

(1616796) Gas panel - Central venous blood

1.55

0.56

3.3

3.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1.55

0.56

1.1

1.55

1.42

g/l

—

(3016502) Oxygen saturation in Arterial blood

350

1.22

0.55

4.8

11.4

96.31

95.21

1.14

341

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

890

1.15

0.55

2.0

2.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1.51

0.54

1.0

1.1

—

20.00

—

(40758558) Short blood count panel - Blood

120

1094

1.14

0.54

6.7

6.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1.59

0.54

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.59

0.54

2.7

3.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

499

0.82

0.54

1.7

1.6

—

(40761536) Microorganisms panel - Urine sediment

304

0.78

0.54

3.0

3.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.44

0.52

1.2

—

(3002179) Metamyelocytes/Leukocytes in Blood

313

0.79

0.52

4.4

4.8

0.29

0.54

—

100

(3030467) Casts [#/volume] in Urine by Automated count

113

1030

1.13

0.51

3.0

3.2

0.31

0.42

e6/l

0.37

747

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

684

0.86

0.50

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

235

1.25

0.49

1.2

—

(3008898) HLA-B27 [Presence]

164

1.30

0.47

1.1

—

(3002256) Pathology report gross observation

459

0.83

0.47

1.2

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

119

0.67

0.46

1.3

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

130

1.32

0.44

1.2

1.4

96.80

268.70

miu/ml

—

(4024509) Urine culture

166

1.28

0.44

2.0

1.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

140

1497

0.90

0.43

1.9

1.33

1.36

mmol/l

0.15

121

1265

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

113

1.34

0.43

1.4

1.3

—

(3016879) Cocaine [Presence] in Urine

203

1.25

0.43

1.3

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

161

1513

1.11

0.43

3.6

0.00

0.02

estimate

1.08

370

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.65

0.43

1.8

1.7

—

(3039000) Anion gap in Blood by calculation

1.44

0.43

5.4

14.9

11.00

11.18

mmol/l

—

(3018572) Chloride [Moles/volume] in Blood

1.44

0.43

5.4

14.9

105.75

104.78

mmol/l

—

(3037121) Protein [Mass/volume] in Urine

131

1.31

0.42

6.9

3.8

3722.14

346.02

mg/l

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.39

0.42

1.4

1.9

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.57

0.42

1.2

—

(3025159) Blasts/Leukocytes in Blood

314

0.82

0.41

4.7

5.5

0.00

0.18

—

(3018095) Leukocytes [#/volume] in Urine

145

1358

1.10

0.41

4.0

36.69

110.44

e6/l

1.54

112

945

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.41

0.0

3.5

—

10.25

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.41

0.0

3.5

—

4.69

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.41

0.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.40

0.0

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.40

0.0

3.7

—

726.39

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

3.5

—

35.37

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

0.40

0.0

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

102

0.68

0.40

1.7

1.6

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

104

0.67

0.40

1.3

1.2

—

(3021901) Oxygen saturation in Capillary blood

1.37

0.38

2.4

2.8

94.37

90.22

—

(3024928) Oxygen saturation in Venous blood

1.37

0.36

2.4

3.8

53.47

61.20

0.64

(3048929) Epstein Barr virus Ab [Presence] in Serum

168

0.77

0.36

1.2

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.27

0.36

1.2

1.1

—

(40768443) Skin Pathology biopsy report

144

1.26

0.36

1.1

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

520

1.13

0.35

1.9

2.4

22.03

23.28

0.37

489

(3035933) Granulocytes/Leukocytes in Blood

0.62

0.35

1.8

2.9

57.22

58.45

—

(3037522) Nuclear Ab [Titer] in Serum

530

1.13

0.35

1.4

316.92

517.02

titre

1.01

121

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

529

0.87

0.35

2.5

2.2

—

(3017732) Neutrophils [#/volume] in Blood

454

1.14

0.35

2.9

4.09

5.73

e9/l

0.71

406

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

127

1.27

0.34

1.7

1.4

0.10

0.01

iu/ml

—

(3041354) Potassium [Moles/volume] in Venous blood

1.34

0.34

2.0

2.6

3.98

4.00

mmol/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.34

0.34

2.0

2.6

1.21

1.18

mmol/l

—

(3035285) Chloride [Moles/volume] in Venous blood

1.34

0.34

2.0

2.6

106.83

105.56

mmol/l

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.68

0.33

1.2

6.4

—

489.00

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1.31

0.33

1.3

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

600

1.12

0.33

1.7

2.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

453

0.87

0.32

2.0

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

137

1.25

0.32

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

476

1.13

0.32

1.4

1.6

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

400

1.14

0.32

4.6

10.3

4.84

5.13

kpa

1.45

385

(3041096) Erythrocytes [Presence] in Urine by Automated

107

1142

0.91

0.32

2.7

3.1

0.00

0.07

estimate

0.52

354

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.35

0.31

1.1

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

896

0.91

0.31

2.4

2.9

334.92

340.40

umol/l

0.21

798

(40768793) Breast Pathology biopsy report

0.71

0.31

1.6

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

355

0.86

0.30

3.1

3.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

317

1.15

0.29

2.5

2.2

—

(3044941) Cell count panel - Synovial fluid

1.23

0.29

1.3

—

(3018418) pH of Serum or Plasma

104

1106

0.92

0.28

4.8

4.0

7.39

7.40

0.40

772

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

271

1.16

0.28

1.9

2.3

6.40

6.21

ug/l

0.03

234

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

362

0.87

0.27

1.8

2.4

36.60

31.73

u/l

0.16

305

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

273

1.15

0.26

2.5

2.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.24

0.25

1.2

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

142

1.21

0.25

1.8

1.7

339.88

314.40

mu/l

0.18

133

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.19

0.25

1.3

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.19

0.25

1.4

1.6

—

(1002224) Polysomnography panel

201

0.84

0.24

1.0

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

823

0.92

0.24

1.9

2.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

152

1.19

0.24

1.7

1.9

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

134

1.20

0.23

1.1

1.48

1.56

g/l

0.70

134

(3000764) Benzodiazepines [Presence] in Urine

219

1.15

0.23

1.3

1.6

—

(3003396) Base excess in Arterial blood by calculation

392

1.11

0.22

4.8

10.5

-0.01

0.92

mmol/l

0.65

333

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

1.22

0.22

1.0

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1.22

0.22

1.4

1.3

2.60

3.45

ug/l

—

(3028300) Cannabinoids [Presence] in Urine

220

1.15

0.21

1.3

1.5

—

(3027008) Opiates [Presence] in Urine

220

1.15

0.21

1.3

1.5

—

(3044007) Cell count panel - Peritoneal fluid

0.00

0.21

0.0

1.2

—

(3034426) Prothrombin time (PT)

0.00

0.21

0.0

1.5

—

27.18

—

(3042733) HLA Ab [Presence] in Serum

0.00

0.21

0.0

2.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.4

—

4.17

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.3

—

(3033799) Differential panel - Peritoneal fluid

0.00

0.21

0.0

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.02

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.8

—

42.78

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

104

0.76

0.21

1.9

1.7

—

(3024471) HLA-A [Type]

0.00

0.21

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

46.96

—

(3024932) HLA-DR beta [Type]

0.00

0.21

0.0

1.2

—

(3013727) Leukocytes other/Leukocytes in Blood

0.00

0.21

0.0

5.1

—

48.21

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.6

—

0.60

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.21

0.0

1.4

—

(3002619) Bacteria identified in Specimen by Culture

0.00

0.21

0.0

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

529

1.09

0.21

2.4

103.00

100.04

ug/g

0.05

416

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

0.21

0.0

6.6

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

0.21

0.0

7.5

—

8.77

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.21

0.0

3.8

—

36.62

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3027944) Amphetamines [Presence] in Urine

221

1.14

0.20

1.3

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

183

1.16

0.20

1.5

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

643

0.92

0.20

2.9

3.2

0.78

0.77

ug/l

0.02

405

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

113

0.79

0.20

1.0

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1.16

0.19

1.3

1.8

—

(4035726) Immunohistochemistry procedure

300

0.89

0.18

1.1

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

329

1.10

0.18

5.4

11.3

127.72

121.34

g/l

0.92

322

(3039443) Prostate specific Ag panel - Serum or Plasma

1.19

0.18

1.1

1.6

—

(3021788) Differential panel - Synovial fluid

1.19

0.18

1.3

1.4

—

(3023368) Bacteria identified in Blood by Culture

100

956

1.06

0.17

3.3

4.3

—

(3019977) pH of Arterial blood

398

1.09

0.17

4.8

10.5

7.43

7.42

0.82

226

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

0.75

0.17

1.6

1.3

30.88

21.11

u/l

—

(40768800) Prostate Pathology biopsy report

0.74

0.17

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

389

1.09

0.17

2.0

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

692

1.07

0.17

3.7

2.8

2.45

mmol/l

0.02

619

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

130

0.84

0.16

2.3

5.3

1.13

1.37

mg/l

1.04

121

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.79

0.15

1.3

2.6

10.67

8.36

pmol/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.76

0.15

1.8

1.6

40.02

58.51

ug/l

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

586

1.07

0.15

2.6

3.1

4.05

2.42

e6/l

0.47

283

(3025941) Bacteria identified in Stool by Culture

223

0.89

0.15

1.1

1.2

—

(3042936) Bacteria identified in Isolate by Culture

521

0.93

0.14

1.8

2.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.78

0.14

1.7

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.78

0.14

1.3

1.2

—

1.03

—

(3026008) Bacteria identified in Urine by Culture

112

1082

1.05

0.14

3.3

2.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

570

0.94

0.13

2.5

2.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

180

1.12

0.13

1.3

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

108

0.83

0.13

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

111

1145

0.96

0.12

4.2

2.63

8.99

mg/mmol

3.88

721

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

220

1.10

0.12

1.3

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

841

0.95

0.12

4.6

20.63

21.65

0.29

397

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

147

0.88

0.11

1.3

—

(3049717) Cytology report of Urine Cyto stain

124

1.13

0.11

2.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.17

0.11

1.1

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

115

0.87

0.11

1.4

1.2

—

3.22

—

(40760892) CBC W Ordered Manual Differential panel - Blood

869

0.96

0.10

5.1

4.9

—

(3021589) Normoblasts [#/volume] in Blood

167

1703

0.97

0.10

9.5

11.3

0.00

e9/l

0.62

137

1397

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

1.14

0.10

1.6

3.5

2.16

7.07

nmol/l

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

164

1.10

0.10

2.3

2.5

—

(3023410) Appearance of Cerebral spinal fluid

1.11

0.10

1.2

1.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1.06

0.09

1.0

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

421

0.94

0.09

1.8

2.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

420

0.95

0.09

1.4

1.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

104

1014

1.03

0.08

2.8

3.5

595.93

1140.31

ng/l

3.73

861

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

144

0.90

0.08

1.4

2.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.03

0.08

1.0

1.8

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.79

0.08

1.4

1.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

283

1.06

0.08

1.5

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.14

0.08

2.0

1.8

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1.10

0.08

1.0

1.5

—

220.00

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

195

1.08

0.08

5.1

14.5

17.03

15.63

1.15

187

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

156

1.09

0.08

2.5

6.0

24.64

24.95

mmol/l

0.25

148

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

123

0.89

0.08

2.1

1.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.08

0.07

1.3

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

600

1.04

0.07

2.2

2.4

13.23

13.28

umol/l

0.02

562

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

112

0.89

0.07

1.5

1.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

326

0.95

0.07

1.6

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.88

0.07

1.8

1.5

—

(21494755) Public health laboratory ask at order entry panel

356

0.95

0.07

1.4

—

(3000492) Spirometry study

376

0.95

0.06

1.3

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

701

1.03

0.06

3.8

3.9

112.36

369.37

ng/l

1.16

524

(3009508) Creatinine [Moles/volume] in Urine

128

1258

1.03

0.06

3.4

3.3

7.90

7.86

mmol/l

0.03

106

1065

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

703

1.03

0.05

1.8

429.19

442.06

pmol/l

0.20

601

(3026782) Osmolality of Urine

713

1.03

0.05

3.0

2.8

563.97

536.30

mosm/kgh2o

0.43

626

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

141

0.92

0.05

2.0

1.8

38.46

39.62

nmol/l

0.09

136

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

139

1.08

0.05

1.2

1.4

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

304

3058

0.98

0.05

16.9

19.0

13.42

13.53

1.11

293

3031

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

120

1.09

0.05

2.2

2.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

904

1.02

0.04

2.1

2.59

2.85

mg/l

0.62

785

(40768804) Tissue Pathology biopsy report

142

1437

0.98

0.04

2.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

107

1054

1.02

0.04

5.6

5.4

2.08

2.42

ug/l

0.26

949

(3003694) ABO and Rh group [Type] in Blood

108

1096

0.98

0.04

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

261

0.96

0.04

1.7

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

119

0.92

0.04

1.1

1.3

—

86.00

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

448

1.03

0.04

1.7

1.9

—

(40768797) Stomach Pathology biopsy report

489

1.03

0.03

1.3

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

279

0.97

0.02

1.8

3.9

1.23

mmol/l

0.10

240

(1761482) Bacteria [#/volume] in Urine by Culture

1.08

0.02

3.7

3.9

—

(3012516) Albumin [Mass/volume] in Urine

111

1119

0.99

0.01

3.9

3.5

20.81

51.88

mg/l

2.47

727

(3001122) Ferritin [Mass/volume] in Serum or Plasma

176

1751

1.01

0.01

2.9

3.0

138.95

117.78

ug/l

0.23

163

1631

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

106

0.94

0.01

9.1

3.3

24.29

27.53

mg/l

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

106

0.94

0.01

9.1

3.3

37.94

109.41

mg/l

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

154

1534

1.01

0.00

5.2

5.0

35.99

36.04

g/l

0.05

146

1455

(3028626) Oxygen [Partial pressure] in Capillary blood

109

1.01

0.00

2.3

6.0

9.45

8.52

kpa

1.65

109

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

269

1.00

0.00

4.4

2.8

65.08

65.09

ml/min/173m2

0.00

119

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

103

0.97

0.00

1.7

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

107

1.03

0.00

1.3

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

145

0.96

0.00

1.9

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

103

1027

1.00

0.00

1.7

18.77

20.60

nmol/l

0.76

872

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

104

0.96

0.00

1.5

1.8

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

296

1.01

0.00

1.9

3.60

3.48

mmol/l

0.22

221

(3001019) Free T4 and TSH panel - Serum or Plasma

166

1.03

0.00

1.4

1.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

496

1.01

0.00

4.5

7.8

104.82

104.05

mmol/l

0.52

496

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.0

1.0

—

7.17

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.00

0.0

5.0

—

5.62

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.91

0.00

1.3

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.0

—

3.57

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.0

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.91

0.00

1.6

1.5

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

2.8

—

39.67

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

0.00

-0.00

0.0

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

6.6

—

(3019174) dRVVT (LA screen)

0.00

-0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

0.01

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

-0.00

0.0

1.2

—

71.40

—

(40757373) Influenza virus identified in Isolate

0.00

-0.00

0.0

1.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

-0.00

0.0

5.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

8.14

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.4

—

44.00

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.9

—

5.19

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

390

1.00

-0.00

2.3

2.1

3.38

3.42

ratio

0.05

316

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.8

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

5.10

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

-0.00

0.0

1.2

—

(44806118) Parainfluenza type 4 nucleic acid detection

0.85

-0.00

1.8

1.7

—

(44790047) Parainfluenza type 1 nucleic acid detection

0.85

-0.00

1.8

1.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.91

-0.00

1.8

1.2

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

0.00

-0.00

0.0

1.4

—

28.20

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

0.00

-0.00

0.0

2.3

—

3.00

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.02

-0.00

1.7

1.1

—

(3014891) Appearance of Pleural fluid

0.00

-0.00

0.0

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.00

-0.00

1.2

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

-0.00

0.0

1.6

—

59.86

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.95

-0.00

1.3

1.1

—

54.90

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

-0.00

0.0

2.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

-0.00

0.0

1.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

4.0

—

57.22

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

13.23

—

(44790049) Parainfluenza type 3 nucleic acid detection

0.85

-0.00

1.8

1.7

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.00

-0.00

0.0

2.2

—

3703.40

—

(44806071) Cardiolipin IgM antibody measurement

0.00

-0.00

0.0

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.98

-0.00

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

-0.00

0.0

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.9

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

4.8

—

4.44

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(44790048) Parainfluenza type 2 nucleic acid detection

0.85

-0.00

1.8

1.7

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_CONTACT_W_VENOMO_SNAKES_LIZAR – Contact with venomous snakes and lizards

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Contact with venomous snakes and lizards

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Contact with venomous snakes and lizards (VWXY20_CONTACT_W_VENOMO_SNAKES_LIZAR)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints